GEN Exclusives

More »

Market and Technology Analysis

More »
Jan 30, 2014

Laboratory-Developed Tests Based on Mass Spec

In the realm of diagnostic tests, MS is making an impact.

Laboratory-Developed Tests Based on Mass Spec

A large number of LDTs based on mass spec are currently in the marketplace. [© Fotolia.com]

  • The focus of this GEN Market & Tech Analysis report is our continuing coverage of the mass spectrometry space as it's translating from research to clinic.

    Highlights of this report:

    • Mass spectrometry is making an impact in the clinic in the realm of diagnostic tests.
    • A number of laboratory-developed tests (LDTs) based on mass spectrometry have been developed and commercialized.
    • A wide swath of disease classes is addressed by these tests, which is encouraging as it suggests the deepening impact of mass spectrometry in the clinic arena.
    • We expect a growing number of bona fide diagnostics based on mass spectrometry going forward across a wide range of diseases/therapeutic indications.

    CLICK HERE to download the PDF report.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »